Latest Breaking News On - Inozyme pharma inc - Page 6 : comparemela.com

HC Wainwright Research Analysts Lift Earnings Estimates for Inozyme Pharma, Inc. (NASDAQ:INZY)

Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Equities research analysts at HC Wainwright boosted their FY2023 EPS estimates for shares of Inozyme Pharma in a research note issued to investors on Wednesday, November 8th. HC Wainwright analyst E. White now forecasts that the company will earn ($1.31) per share for the year, up from […]

United-states
Inozyme-pharma
Virtu-financial
Nasdaq
Barclays-plc
Needham-company
Inozyme-pharma-inc
Inozyme-pharma-company-profile
Citigroup-inc
Free-report
Pharma-stock-down
Get-free-report

Inozyme Pharma (NASDAQ:INZY) Rating Reiterated by Wedbush

Inozyme Pharma (NASDAQ:INZY – Get Free Report)‘s stock had its “outperform” rating restated by equities researchers at Wedbush in a report released on Tuesday, RTT News reports. They presently have a $15.00 price target on the stock. Wedbush’s price target indicates a potential upside of 368.75% from the company’s previous close. A number of other […]

United-states
Inozyme-pharma
Citigroup-inc
Renaissance-technologies
Needham-company
Inozyme-pharma-inc
Blackrock-inc
Get-free-report
Rock-springs-capital-management
Springs-capital-management
Inozyme-pharma-daily
Nasdaq-inzy

Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights

– Patient recruitment underway in ENERGY-3 Pivotal Trial of INZ-701 in pediatric patients with ENPP1 Deficiency; topline data expected mid-2025 –

United-states
Boston
Massachusetts
American
Stefan-riley
Douglasa-treco
Inozyme-pharma
Matt-pera
Pamerican-society-for-bone
Drug-administration
Inozyme-pharma-inc
Development-rd-expenses

Inozyme Pharma (INZY) Files $300M Mixed Shelf

Inozyme Pharma (INZY) Files $300M Mixed Shelf
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasdaq
Inozyme-pharma-inc
Inozyme-pharma

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Inozyme-pharma
Inozyme-pharmastefan-riley
Smithsolvematt-pera
Facebook
Inozyme-pharma-inc
Linkedin
Nasdaq
Company-or-inozyme
Twitter